Harnessing the immune response to target tumors. - Wikidata - awgldk - TriplyDB

Harnessing the immune response to target tumors.

Harnessing the immune response to target tumors.

http://www.wikidata.org/entity/Q39377265

about

Harnessing the immune response to target tumors.

http://www.wikidata.org/entity/Q39377265

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Harnessing the immune response to target tumors.

@en

Harnessing the immune response to target tumors.

@nl

type

label

Harnessing the immune response to target tumors.

@en

Harnessing the immune response to target tumors.

@nl

prefLabel

Harnessing the immune response to target tumors.

@en

Harnessing the immune response to target tumors.

@nl

P1433

Q39377265-6D62CCAE-4E94-48CE-8B9B-6AFBF1CBB03B

P1476

Q39377265-78796980-6F9B-494F-B594-69D821AEFBE7

P2093

Q39377265-376BBC56-A7D7-4E62-8D0D-1CC2A269FC52

P2860

Q39377265-019A9629-BB49-4B29-A613-028A1B3F900C

Q39377265-06C1A789-7E7D-4931-AFC7-E999A11D1AD8

Q39377265-06EB83D6-E653-4863-A57E-FA7A06B0F1B7

Q39377265-08CD0D25-4E08-4625-BC7F-B0283629F2F1

Q39377265-08FACAFB-80C8-4A1E-9FE5-F952CA69DC11

Q39377265-0CB49EEC-95A6-4CAD-8977-A8BC43875C73

Q39377265-0CF1947F-93CB-4ECC-A7DE-EA546761E855

Q39377265-0CF33575-769A-404D-9CFD-F31E3C7F03AD

Q39377265-0F297D15-7478-4459-A297-E3960CB21223

Q39377265-0F707BD7-EAD3-4004-AF80-CA0B0DFE8D2B

P304

Q39377265-F2AD1126-6E83-40D6-B6F8-61971679D88C

P31

Q39377265-885407B1-F1BB-473D-BFD5-2478EABACF89

P356

Q39377265-9C91B0CC-6007-42C1-AD22-EACC60CDBC62

P478

Q39377265-6E637396-00AC-4AB5-AAA0-C8F52FBD47DC

P50

Q39377265-DAA207DD-85C1-4EB7-882F-717E75393ED2

P577

Q39377265-649298C5-844B-415F-9F99-BDA52C34A9FD

P698

Q39377265-4684DCAA-DB1F-449E-9F85-C12DD9136C70

P932

Q39377265-99A75137-8C9C-4F07-BFFA-0A86CEBADD3B

P356

F1000RESEARCH.10795.1

P1433

P1476

Harnessing the immune response to target tumors.

@en

P2093

Luisa Manning

http://www.w3.org/2001/XMLSchema#string

P2860

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Signatures of mutational processes in human cancer

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

P304

710

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.10795.1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

John Nemunaitis

P577

2017-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28620466

http://www.w3.org/2001/XMLSchema#string

P932

5461900

http://www.w3.org/2001/XMLSchema#string